---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/276621705.md"
description: "Allurion Technologies shares are trading higher after the company announced FDA approval for its gastric balloon system application."
datetime: "2026-02-23T15:48:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276621705.md)
  - [en](https://longbridge.com/en/news/276621705.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276621705.md)
---

# 

Allurion Technologies shares are trading higher after the company announced FDA approval for its gastric balloon system application.

### Related Stocks

- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [ALUR.WS.US](https://longbridge.com/en/quote/ALUR.WS.US.md)
- [ALUR.US](https://longbridge.com/en/quote/ALUR.US.md)

## Related News & Research

- [Forward Industries Q2 revenue rises over 4x, posts $283 mln net loss](https://longbridge.com/en/news/286466469.md)
- [West Pharmaceutical Says Making Progress In Restoring Global Operations After Cyberattack](https://longbridge.com/en/news/286605804.md)
- [POET Technologies GAAP EPS of -$0.08 misses by $0.03, revenue of $0.5M beats by $0.25M](https://longbridge.com/en/news/286510324.md)
- [Edwards Lifesciences CVP, Strategy/Corp Development Sold Shares Worth Over $1.4M](https://longbridge.com/en/news/286822028.md)
- [Implantica submits final FDA response for RefluxStop PMA review](https://longbridge.com/en/news/287013331.md)